Trial of Psilocybin versus Escitalopram for Depression
2021 · New England Journal of Medicine · 1,297 citations
https://doi.org/10.1056/nejmoa2032994
R
Roberta Murphy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
2.0K
Citations
8
h-index
8
i10-index
Roberta Murphy is an academic researcher from Imperial College London. The author has contributed to research in topics: Psychedelics and Drug Studies & Chemical synthesis and alkaloids & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 8, co-authored 11 publications.
Papers by this author
worksEffect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial
2024 · EClinicalMedicine · 37 citations
https://doi.org/10.1016/j.eclinm.2024.102799
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression
2023 · Psychological Medicine · 36 citations
https://doi.org/10.1017/s0033291723001514
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat